During the past decade, Arden Cancer Centre conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arden Cancer Centre" #1 collaborator was "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Myriad Genetic Laboratories, Inc." with 2 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator and "GOG Foundation" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Arden Cancer Centre" are "Advanced Ovarian Cancer" (1 trials), "BRCA Mutated" (1 trials), "BRCA Mutation" (1 trials), "Complete Response" (1 trials) and "FIGO Stage III-IV" (1 trials). Many other conditions were trialed in "Arden Cancer Centre" in a lesser frequency.

Most popular intervention types in "Arden Cancer Centre" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Olaparib 300mg tablets" (2 trials) and "Placebo to match olaparib 300mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Arden Cancer Centre" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Arden Cancer Centre". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Arden Cancer Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Arden Cancer Centre, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".